“A $25B lung-drug maker is the only listed company actually manufacturing product in orbit with Varda; if microgravity crystallization pays off, it gains a whole new growth story on top of its Tyvaso franchise.”
“We make some drugs up there.”
Prices are point-in-time snapshots from the named provider. The verdict compares the return since entry against the band above.